ApoE-Deficient Promotes Blood–Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9

Aging decreases antioxidant effects and increases lipid peroxidation in the Apolipoprotein E deficient mouse

(2013) Taro Honma et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Regulation of Immune Cell Infiltration into the CNS by Regional Neural Inputs Explained by the Gate Theory

(2013) Yasunobu Arima et al.   MEDIATORS OF INFLAMMATION

Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis

(2013) Junjie Wei et al.   NEUROBIOLOGY OF DISEASE

Protein kinase Cβ as a therapeutic target stabilizing blood–brain barrier disruption in experimental autoimmune encephalomyelitis

(2013) Tobias V. Lanz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inflammatory Cytokines at the Summits of Pathological Signal Cascades in Brain Diseases

(2013) L. Steinman   Science Signaling

Cerebrovascular Effects of Apolipoprotein E

(2013) Berislav V. Zlokovic   JAMA Neurology

West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases

(2012) K. Roe et al.   JOURNAL OF GENERAL VIROLOGY

Increase of arginase activity in old apolipoprotein-E deficient mice under Western diet associated with changes in neurovascular unit

(2012) Jérôme Badaut et al.   Journal of Neuroinflammation

Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis

(2012) Mariella Errede et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice

(2012) Nathalie Gaudreault et al.   PLoS One

Immunomodulation by Transplanted Human Embryonic Stem Cell-Derived Oligodendroglial Progenitors in Experimental Autoimmune Encephalomyelitis

(2012) Heechul Kim et al.   STEM CELLS

Probing cytokines, chemokines and matrix metalloproteinases towards better immunotherapies of multiple sclerosis

(2011) Ghislain Opdenakker et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in anin VitroBlood-Brain Barrier Model

(2011) Kazuchika Nishitsuji et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS Myelination

(2011) C. S. Moore et al.   JOURNAL OF NEUROSCIENCE

Vascular pathology in the aged human brain

(2010) Lea Tenenholz Grinberg et al.   ACTA NEUROPATHOLOGICA

Disruption of central nervous system barriers in multiple sclerosis

(2010) Jorge Ivan Alvarez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice

(2010) Lakshmi Devi Kandagaddala et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4+ FoxP3+T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells

(2010) Abigail C. Buenafe et al.   IMMUNOLOGY

Apolipoprotein E: From lipid transport to neurobiology

(2010) Paul S. Hauser et al.   PROGRESS IN LIPID RESEARCH

Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice

(2009) Michael Thorne et al.   JOURNAL OF NEUROIMMUNOLOGY

Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα)

(2009) Stefan M Gold et al.   LABORATORY INVESTIGATION

Structure and function of the blood–brain barrier

(2009) N. Joan Abbott et al.   NEUROBIOLOGY OF DISEASE

Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies

(2008) Rao Adibhatla et al.   CNS & Neurological Disorders-Drug Targets

Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis

(2008) Q.-X. Sang et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY